Upsher-Smith Laboratories
{{Short description|American pharmaceutical company}}
{{More citations needed|date=September 2017}}
{{Infobox company
| name = Upsher-Smith Laboratories
| logo = USL.jpg
| type = Subsidiary
| industry = Pharmaceuticals
| founded = {{Start date and age|1919}} in Wayzata, Minnesota, U.S.
| location = Maple Grove, Minnesota, U.S.
| key_people = {{Unbulleted list|Taku Nakaoka|{{smaller|(CEO, Chairman)}}{{Cite web |url=https://www.upsher-smith.com/news/taku-nakaoka-named-ceo-of-upsher-smith-laboratories/ |title=Taku Nakaoka Named CEO of Upsher-Smith Laboratories}}|Rich Fisher|{{smaller|(CEO, President)}}{{Cite web |url=https://www.upsher-smith.com/about-us/executive-team/ |title=Executive Team }} }}
| products = {{ubl|generic drugs|pharmaceutical drugs}}
| parent = {{ubl|{{ill|Sawai Group Holdings Co.|jp|サワイグループホールディングス}}|{{smaller|(2017–24)}}|Bora Pharmaceuticals|{{smaller|(2024–present)}}}}
| website = {{URL|http://www.upsher-smith.com}}
}}
Upsher-Smith Laboratories, LLC is an American pharmaceutical company based in Maple Grove, Minnesota. Founded in 1919, it has been owned by Bora Pharmaceuticals since 2024.
History
Founded in 1919 as a maker of digitalis drugs,{{Cite web |url=http://www.upsher-smith.com/about/history.html |title=Upsher-Smith History}} Upsher-Smith has traditionally focused on the manufacture of generic medications.
In 2017, after owning it for 47 years, the Evenstad family decided to sell most of the firm, the generics business, to {{ill|Sawai Group Holdings Co., Ltd.|jp|サワイグループホールディングス}}, a large publicly traded generics company in Japan that had been seeking entry into the U.S. market.{{Cite web |url=http://www.prnewswire.com/news-releases/sawai-pharmaceutical-completes-acquisition-of-upsher-smith-laboratories-generics-business-300466698.html |title=Sawai Pharmaceutical Completes Acquisition of Upsher-Smith Laboratories Generics Business |date=May 31, 2017}} Its non-generic pharmaceutical business, Proximagen, Pairnomix, and MOBĒ, remained with ACOVA, a holding company owned by the Evenstads.
On April 1, 2024, Upsher-Smith Laboratories was acquired by Bora Pharmaceuticals Co., Ltd., considered the largest pharmaceutical manufacturer in Taiwan.{{Cite web|url=https://www.upsher-smith.com/news/bora-pharmaceuticals-completes-the-acquisition-of-upsher-smith/|title= Bora Pharmaceuticals Completes the Acquisition of Upsher-Smith|work=Upsher-Smith|access-date=2024-04-04|language=en}}
Locations
- Maple Grove, Minnesota: Corporate Headquarters{{Cite web |title=Locations – Upsher-Smith |url=https://www.upsher-smith.com/contact-us/locations/ |access-date=2022-06-21 |website=Upsher-Smith Laboratories, LLC |language=en-US}}
- Madison, New Jersey: Corporate Office
- Plymouth, Minnesota: Manufacturing
Products
Upsher-Smith offers brand and generic pharmaceuticals to treat the following disease states:{{Cite web |url=http://www.upsher-smith.com/our-products/products-a-z/ |title=Upsher-Smith Products}}
References
{{Reflist}}
{{Pharmaceutical companies of the United States}}
{{Authority control}}
Category:2017 mergers and acquisitions
Category:American subsidiaries of foreign companies
Category:Health care companies based in Minnesota
Category:Maple Grove, Minnesota
Category:Pharmaceutical companies established in 1919